Oxford AstraZeneca
Latest news and video coverage curated from trusted media outlets
| 0 shares | ShareTweetSavePostSend |
You Might Like
Indian Lawyer Gets Prestigious "Freedom of the City of London" AwardAn India born prolific lawyer, Ajit Mishra, has been conferred with "*Freedom of the City of London Award*" at Guildhall today for his outstanding contribution in legal and public life. Mr Mishra is..NewsVoir - Published | |
Canada set to 'throw out' 13.6 million doses of Oxford-AstraZeneca Covid-19 vaccine, here's whyCanada signed a contract with AstraZeneca in 2020 to get 20 million doses of its vaccine, and 2.3 million Canadians received at least one dose of it.DNA - Published | |
UK marks first anniversary of Oxford/AstraZeneca vaccine deploymentIndiaTimes - Published | |
India-Bangladesh bonhomie scaled new heights as 2021 marked 50 years of tiesThe year began on a promising note as Bangladesh PM Sheikh Hasina thanked her Indian counterpart Narendra Modi for sending over two million doses of AstraZeneca-Oxford University vaccine Covishield, as..IndiaTimes - Published | |
Oxford study supports AstraZeneca for third dose against OmicronnewKerala.com - Published | |
AstraZeneca booster dose works against Omicron, says Oxford lab studynewKerala.com - Published Also reported by •DNA | |
Lancet study about Covishield 3 months efficacy misquoted, say expertsThe Lancet study reportedly stated that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months.Zee News - Published | |
Oxford-AstraZeneca begins work on vaccine to target OmicronnewKerala.com - Published | |
Oxford-AstraZeneca Covid vax protection wanes after 3 months: LancetnewKerala.com - Published | |
Poonawalla family pledges $66 million to Oxford University for setting up research campusThe pledge builds on the collaboration between Oxford University, AstraZeneca and SII, the world`s largest maker of vaccines and the producer of a version of the British duo`s COVID-19 shot for low-..Zee News - Published | |
Next pandemic could be more lethal than Covid, vaccine creator saysFuture pandemics could be even more lethal than Covid-19 so the lessons learned from the outbreak must not be squandered and the world should ensure it is prepared for the next viral onslaught, one of..IndiaTimes - Published | |
Covid-19: A wide range of vaccines act as booster to AstraZeneca, Pfizer shots, says studyUp to six different Covid-19 boosters were found to be safe, and provoked strong immune responses in people who have previously received a two-dose course of the Oxford-AstraZeneca-developed..IndiaTimes - Published | |
Good news for Indian travellers! UK to add Covaxin to approved list from November 22The move follows the World Health Organisation's (WHO) Emergency Use Listing for Covaxin, which is the second most used formulation in India. Covishield, the India-manufactured Oxford-AstraZeneca..Zee News - Published | Russia stole blueprint for Oxford/AstraZeneca vaccine to make Sputnik V, allege sourcesPreviously, MI5 operatives have stated that multiple cyber strikes on Oxford University were attempted by Russian hackers on March 2020. This was a month after British scientists revealed they had..Zee News - Published |
Covid virus to get weaker, become a cold: Oxford-AstraZeneca vax creatornewKerala.com - Published | Vaccine certification for travel must meet ‘minimum criteria’, working closely with India: UKThe UK government has assured that it is working with India on “a phased approach” to its international travel norms. The development came after the UK government said that Covishield, the Serum..Zee News - Published |
Oxford AstraZeneca COVID-19 vaccine can set off this nerve disorder, says European Medicines AgencyThe nerve disorder as a possible side-effect of AstraZeneca vaccine is categorized in the lowest occurrence category of side-effects, as "very rare."DNA - Published | Oxford-AstraZeneca vaccine team receive ‘hero’ award at GQ Men of the Year 2021Indian Express - Published |
Pfizer, AstraZeneca COVID-19 vaccines less effective against Delta variant: Oxford studyTwo doses of either vaccine still provided at least the same level of protection as having had COVID-19 before through natural infection, the Oxford-based researchers said.Zee News - Published | Side effects of Janssen's COVID vaccineJohnson & Johnson's COVID-19 vaccine has received emergency use approval (EUA) in India, becoming the fifth vaccine to be approved after Oxford-AstraZeneca's Covishield, Bharat Biotech's Covaxin,..IndiaTimes - Published |
France allows Covishield vaccinated travellers, check list of countries to recognise India-made vaccineCovishield is now recognised and accepted Oxford-Astrazeneca vaccine for entry of international travellers.Zee News - Published | Oxford AstraZeneca vaccine may provide 'protection for life', finds new UK studyThe study says the Oxford AstraZeneca vaccine, a version of which is manufactured as Covishield in India, might offer protection lasting a lifetime.DNA - Published |
UK gets Malta to permit India-made Oxford/AstraZeneca vaccine travellersIndian Express - Published | Zydus Cadila's COVID vaccine: How it works?The second wave of coronavirus highlighted not just the unpredictability of the SARs-COV-2 virus but also emphasized on the importance of COVID vaccines. As of now, apart from locally manufactured..IndiaTimes - Published |
Sarah Gilbert, lead scientist behind Oxford-AstraZeneca COVID-19 vaccine, gets standing ovation at Wimbledon -- WatchThe Wimbledon spectators also applauded the efforts of organisations that have contributed to Britain's fight against COVID-19.Zee News - Published | Travel to Europe still a worry as India-made Covishield yet to get European Union `Green Pass`Even though Covishield has the WHO’s approval, the ‘Green Pass’ program only accommodates EMA-approved vaccines. The four COVID-19 vaccines approved by EMA are Comirnaty (Pfizer/BioNTech),..Zee News - Published |
Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant of COVID-19: UK govt studyThe Oxford/AstraZeneca two-dose vaccine is also being produced by the Serum Institute of India as Covishield and being administered among the adult population in India to protect against the deadly..Zee News - Published Also reported by •IndiaTimes | Get Pfizer or Moderna for second dose after receiving AstraZeneca vaccine, suggests NACICanada`s National Advisory Committee on Immunizations (NACI) said that those who received the first shot of Oxford-AstraZeneca in their vaccination schedule can get vaccinated with a messenger RNA..Zee News - Published |
Oxford-AstraZeneca Covid jab linked to low platelet count: StudynewKerala.com - Published | Covishield produces more antibodies than Covaxin, finds studyCovishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufactured vaccine by Hyderabad-based Bharat Biotech in..IndiaTimes - Published |
Chile temporarily halts Oxford-AstraZeneca vax for people under 45newKerala.com - Published | Chinese vaccine to cost Bangladesh double of India's Oxford-AstraZenecanewKerala.com - Published Also reported by •IndiaTimes |
Oxford, Pfizer vaccines 80% effective against COVID-19 variant found in India: StudyTwo doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK..Zee News - Published Also reported by •IndiaTimes | Two shots of AstraZeneca provide 85-90% efficacy against COVID-19, suggests UK dataPublic Health England (PHE) said that the two doses of the Oxford/AstraZeneca COVID-19 vaccine may provide around 85% to 90% effectiveness against COVID-19 disease.Zee News - Published |
Japan gives green signal to AstraZeneca, Moderna COVID-19 vaccinesAfter the BioNTech Pfizer's COVID-19 vaccine, the Japanese government allows the use of Oxford AstraZeneca and Moderna vaccines for inoculation against coronavirus disease.Zee News - Published | Two AstraZeneca Covid shots 85-90% effective: UK real-world analysisTwo doses of the Oxford/AstraZeneca Covid-19 vaccine are around 85% to 90% effective against symptomatic disease, Public Health England (PHE) said on Thursday, citing an analysis of real-world data..IndiaTimes - Published |
3-month gap between doses improves immune response: AZ vax co-developerA three-month gap between two doses of the AstraZeneca vaccine, known in India as Covishield, improves the immune response against Covid-19, according to Andrew Pollard, co-developer of the vaccine and..IndiaTimes - Published | Study finds slightly increased blood clot rates after AstraZaneca COVID-19 shotA large study in Denmark and Norway has found slightly increased rates of vein blood clots, including in the brain, among adults who had received their first dose of the Oxford-AstraZeneca COVID-19..Zee News - Published |
Powerful Indians making aggressive calls for COVID vaccines: Serum CEO Adar PoonawallaThe Serum Institute chief spoke about receiving aggressive calls from some of the most powerful people in India, demanding supplies of Covishield -- the Oxford/AstraZeneca COVID-19 vaccine that the..Zee News - Published | 5 million doses of COVID-19 vaccine Sputnik V in India by June, says Indian envoy to Russia Venkatesh VarmaNew Delhi: India is set to get 5 million doses of Russian COVID vaccine Sputnik V by June, even as the vaccine is set to be rolled in the country from May 1. Sputnik V is the third vaccine India has..DNA - Published |
